Rate My Professor Ruth Dobson

Professor Ruth Dobson is Professor of Clinical Neurology and Centre Lead for the Centre of Preventive Neurology at the Wolfson Institute of Population Health within the Faculty of Medicine and Dentistry at Queen Mary University of London. She serves as Honorary Consultant Neurologist at Barts Health NHS Trust, with a subspecialty interest in multiple sclerosis. Her academic background includes an MB BS from the University of London, a PhD from the Blizard Institute at Queen Mary University of London, and fellowship of the Royal College of Physicians (FRCP). Dobson's research centers on the roles of ethnicity, deprivation, gender, and wider social determinants of health in multiple sclerosis, emphasizing equitable representation of all patients in research studies. She led the publication of the UK consensus guidelines on pregnancy in multiple sclerosis in 2019 and directs the UK MS Pregnancy Register.

Dobson holds prominent leadership roles, including Chair of the Association of British Neurologists Advisory Group for MS and neuroinflammation, member of the NHS England Neurology Clinical Reference Group, UK representative on the ECTRIMS Council, Strategic Lead for Dementia at UCL Partners, Chair of the MS Trust Advisory Group, Chair of the Cure Parkinson’s Trust Research Committee, and Chair of the Research, Culture and Environment Committee for the Faculty of Medicine and Dentistry at Queen Mary University of London. She has received the Royal College of Physicians Emerging Women Leader recognition in 2020 and the MS Brain Health Award in 2023 for her contributions to pregnancy and MS research. Her work has been funded by the National Multiple Sclerosis Society, MS Society, Horne Family Foundation, Barts Charity, BMA Foundation, MRC, and NIHR. With over 140 peer-reviewed publications, key works include 'UK consensus on pregnancy in multiple sclerosis: Association of British Neurologists’ guidelines' (2019), 'Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk' (2020), 'Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study' (2021), and recent contributions such as 'Toward a global research agenda for preventing multiple sclerosis' (2026). Her efforts have advanced understanding of MS epidemiology, informed clinical guidelines, and promoted equity in neurology.